9 results
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... • Euglycemic diabetic ... #Inhibitors #Pharmacology ... #Summary #DM2 #
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Diabetes Combination ... Tablets - Estimated A1c ... Metformin + SGLT2 ... Tablets #Oral #DM2 ... #Pharmacology #
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... class of anti-diabetic ... #Inhibitors #Pharmacology ... #Medications #DM2
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes ... CARB ABSORPTION INHIBITOR ... Prandase) • SGLT ... #Management #pharmacology ... #DM2 #DMII #Classification
Diabetes Medication Choice
-Diabetes Medication Choice decision aid cards provide information on medications commonly used to treat
Choice -Diabetes ... only metformin, SGLT-i ... #Type2 #DM2 #PatientInfo ... #SideEffects #A1c ... Reduction #Costs #Pharmacology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP-4 inhibitor ... receptor agonist, SGLT2i ... α-glucosidase inhibitor ... #Mellitus #DM2 ... #Medications #pharmacology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... has a smaller A1c ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Methotrexate Toxicology 

Intravenous leucovorin (folinic acid) treatment serves as a cofactor necessary for synthesis of thymidylate
Methotrexate Toxicology ... ineffective because MTX inhibits ... , up to 100 mg/m2 ... #Toxicity #Management ... #Pharmacology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
, 350 mg/m2, and ... system (RAAS) inhibitor ... hypertension, diabetes ... cardiology #oncology #pharmacology ... #toxicity #chemotherapy